Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hak Choy

Showing results (41-50 of 140) with videos related to

Pageof 14
Sort By:
Lung Cancer (Amsterdam, Netherlands)|July 27, 2005
Long term follow up and analysis of long term survivors in patients treated with paclitaxel-based concurrent chemo/radiation therapy for locally advanced non-small cell lung cancerDong Wook Kim, Yu Shyr, Bashar Shaktour, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 18, 2003
Potential radiation-sensitizing effect of semisynthetic epothilone B in human lung cancer cellsJae-Chul Kim, Jae-Sung Kim, Debabrata Saha, et al.
International Journal of Radiation Oncology, Biology, Physics|May 26, 2005
Response to combined modality therapy correlates with survival in locally advanced non-small-cell lung cancerDong Wook Kim, Yu Shyr, Heidi Chen, et al.
JAMA Oncology|December 21, 2018
The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Made Simple for Medical and Radiation Oncologists: A Narrative ReviewRyan T Jones, Bonnie Helm, Dominick Parris, et al.
International Journal of Radiation Oncology, Biology, Physics|December 20, 2013
Localization accuracy and immobilization effectiveness of a stereotactic body frame for a variety of treatment sitesRyan Foster, Jeffrey Meyer, Puneeth Iyengar, et al.
Cancer Research and Treatment|December 19, 2015
Combined Modality Therapy for Locally Advanced Non-Small Cell Lung CancerL Chinsoo Cho, J Michael Dimaio, Randall Hughes, et al.
Cancer Research|October 30, 2003
The antiangiogenic agent SU5416 down-regulates phorbol ester-mediated induction of cyclooxygenase 2 expression by inhibiting nicotinamide adenine dinucleotide phosphate oxidase activityDebabrata Saha, Konjeti R Sekhar, Carolyn Cao, et al.
Frontiers in Oncology|January 22, 2016
The Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial LesionsAaron Michael Laine, Arnold Pompos, Robert Timmerman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 10, 2014
Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancerNathan A Cannon, Jeffrey Meyer, Puneeth Iyengar, et al.
The Journal of Surgical Research|June 19, 2002
Vascular endothelial growth factor-mediated angiogenesis inhibition and postoperative wound healing in ratsChristopher D Roman, Hak Choy, Lillian Nanney, et al.
Pageof 14

Showing results (41-50 of 140) with videos related to

Sort By:
Pageof 14
Lung Cancer (Amsterdam, Netherlands)|July 27, 2005
Long term follow up and analysis of long term survivors in patients treated with paclitaxel-based concurrent chemo/radiation therapy for locally advanced non-small cell lung cancerDong Wook Kim, Yu Shyr, Bashar Shaktour, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 18, 2003
Potential radiation-sensitizing effect of semisynthetic epothilone B in human lung cancer cellsJae-Chul Kim, Jae-Sung Kim, Debabrata Saha, et al.
International Journal of Radiation Oncology, Biology, Physics|May 26, 2005
Response to combined modality therapy correlates with survival in locally advanced non-small-cell lung cancerDong Wook Kim, Yu Shyr, Heidi Chen, et al.
JAMA Oncology|December 21, 2018
The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Made Simple for Medical and Radiation Oncologists: A Narrative ReviewRyan T Jones, Bonnie Helm, Dominick Parris, et al.
International Journal of Radiation Oncology, Biology, Physics|December 20, 2013
Localization accuracy and immobilization effectiveness of a stereotactic body frame for a variety of treatment sitesRyan Foster, Jeffrey Meyer, Puneeth Iyengar, et al.
Cancer Research and Treatment|December 19, 2015
Combined Modality Therapy for Locally Advanced Non-Small Cell Lung CancerL Chinsoo Cho, J Michael Dimaio, Randall Hughes, et al.
Cancer Research|October 30, 2003
The antiangiogenic agent SU5416 down-regulates phorbol ester-mediated induction of cyclooxygenase 2 expression by inhibiting nicotinamide adenine dinucleotide phosphate oxidase activityDebabrata Saha, Konjeti R Sekhar, Carolyn Cao, et al.
Frontiers in Oncology|January 22, 2016
The Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial LesionsAaron Michael Laine, Arnold Pompos, Robert Timmerman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 10, 2014
Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancerNathan A Cannon, Jeffrey Meyer, Puneeth Iyengar, et al.
The Journal of Surgical Research|June 19, 2002
Vascular endothelial growth factor-mediated angiogenesis inhibition and postoperative wound healing in ratsChristopher D Roman, Hak Choy, Lillian Nanney, et al.
Pageof 14